| Company Name: |
Sigma-Aldrich |
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Company Name: |
Lynnchem |
| Tel: |
86-(0)29-85992781 17792393971 |
| Email: |
info@lynnchem.com |
| Company Name: |
Novachemistry |
| Tel: |
44-20819178-90 02081917890 |
| Email: |
info@novachemistry.com |
|
| | NORCHLORDIAZEPOXIDE Basic information |
| Product Name: | NORCHLORDIAZEPOXIDE | | Synonyms: | NORCHLORDIAZEPOXIDE;2-Amino-7-chloro-5-phenyl-3H-1,4-benzodiazepine 4-oxide;Desmethylchlordiazepoxide;Norchlordiazepoxide solution;3H-1,4-Benzodiazepin-2-amine, 7-chloro-5-phenyl-, 4-oxide;3h-1,4-benzodiazepin-2-amine,7-chloro-5-phenyl-,4-oxide,hydrochloride;3H-1,4-Benzodiazepine, 2-amino-7-chloro-5-phenyl-, 4-oxide;7-Chloro-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide | | CAS: | 7722-15-8 | | MF: | C15H12ClN3O | | MW: | 285.73 | | EINECS: | | | Product Categories: | Aromatics;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals | | Mol File: | 7722-15-8.mol |  |
| | NORCHLORDIAZEPOXIDE Chemical Properties |
| Boiling point | 532.5±60.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | Fp | 2℃ | | storage temp. | room temp | | solubility | DMSO (Slightly), Methanol (Slightly, Heated) | | pka | 2.10±0.20(Predicted) | | form | Solid | | color | Off-White to Pale Yellow | | Major Application | clinical testing | | InChI | 1S/C15H12ClN3O/c16-11-6-7-13-12(8-11)15(10-4-2-1-3-5-10)19(20)9-14(17)18-13/h1-8H,9H2,(H2,17,18) | | InChIKey | LNLMGKOHYYEWMY-UHFFFAOYSA-N | | SMILES | ClC1=CC2=C(N=C(N)C[N+]([O-])=C2C3=CC=CC=C3)C=C1 |
| Hazard Codes | F,Xn | | Risk Statements | 11-20/21/22-36 | | Safety Statements | 16-26-36/37 | | RIDADR | UN 1648 3 / PGII | | WGK Germany | 2 | | Storage Class | 3 - Flammable liquids | | Hazard Classifications | Acute Tox. 4 Dermal
Acute Tox. 4 Inhalation
Acute Tox. 4 Oral
Eye Irrit. 2
Flam. Liq. 2 |
| | NORCHLORDIAZEPOXIDE Usage And Synthesis |
| Chemical Properties | Off-White to Pale Yellow Soild | | Uses | The main metabolite of Chlordiazepoxide (C327050). | | General Description | Norchlordiazepoxide is a major urinary metabolite of the benzodiazepine chlordiazepoxide, indicated for short term treatment of severe anxiety and for the management of acute alcohol withdrawal syndrome. The metabolite, also known as N-desmethylchlordiazepoxide, is pharmacologically active. This Certified Spiking Solution is suitable for GC/MS or LC/MS methods in chlordiazepoxide testing for forensic analysis, urine drug testing, or clinical toxicology. |
| | NORCHLORDIAZEPOXIDE Preparation Products And Raw materials |
|